Biogen shares rose more than 5 percent in pre-market trading after the company reported that BIIB037 showed effects on cognition and reduced amyloid plaques in the brain.
(0)
(0)
Deliver breaking news, insightful commentary, and exclusive reports. Get in touch
benzingaheadline@gmail.com.
Target readers who trust our platform to stay ahead of the curve.